In the BioHarmony Drug Report Database
Desoximetasone
Topicort, Topicort Lp, Neofordex, Ozurdex (desoximetasone) is a small molecule pharmaceutical. Desoximetasone was first approved as Topicort on 1982-01-01. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis. The pharmaceutical is active against glucocorticoid receptor. Topicort’s patent is valid until 2028-09-01 (FDA).
Trade Name
|
Neofordex, Ozurdex |
|---|---|
Common Name
|
desoximetasone |
ChEMBL ID
|
CHEMBL1766 |
Indication
|
facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, macular edema, multiple myeloma, scalp dermatoses, uveitis |
Drug Class
|
Image (chem structure or protein)